Lmcg Investments LLC Has $4.01 Million Holdings in Cigna Group $CI

Lmcg Investments LLC lessened its holdings in shares of Cigna Group (NYSE:CI) by 3.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,120 shares of the health services provider’s stock after selling 494 shares during the quarter. Lmcg Investments LLC’s holdings in Cigna Group were worth $4,007,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD increased its position in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after buying an additional 1,094,327 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 0.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after buying an additional 98,715 shares during the last quarter. Dodge & Cox increased its position in Cigna Group by 1.3% during the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock worth $2,924,722,000 after buying an additional 117,125 shares during the last quarter. GQG Partners LLC increased its position in Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its position in Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after buying an additional 3,471,249 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 1.7%

Shares of NYSE:CI opened at $301.00 on Friday. The company has a market capitalization of $80.35 billion, a P/E ratio of 16.43, a P/E/G ratio of 0.90 and a beta of 0.45. Cigna Group has a 1 year low of $256.89 and a 1 year high of $358.88. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The business’s 50 day simple moving average is $294.68 and its 200 day simple moving average is $309.31.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the business posted $6.72 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group’s dividend payout ratio is presently 32.97%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Guggenheim reissued a “buy” rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $415.00 target price on Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Robert W. Baird set a $372.00 target price on Cigna Group in a research report on Thursday, August 14th. Truist Financial set a $375.00 target price on Cigna Group in a research report on Tuesday, September 2nd. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $372.69.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.